In early October of 2019, doTERRA made waves by partnering with St. Elizabeth Healthcare based in the Greater Cincinnati region, pledging to play a fundamental role in the development of the Center for Integrative Oncology within the Cancer Center. 

Since this announcement, the staff at St. Elizabeth have continued their commitment to the betterment of the community.

The Cincinnati Inquirer recently reported that St. Elizabeth Healthcare is the first U.S. location to offer a clinical trial of an inhaled drug to potentially limit the spread and severity of COVID-19. Early studies have shown promise in the drug’s ability to stop COVID-19 before it advances into cases that are more serious.

doTERRA is honored to be working with St. Elizabeth Healthcare who is committed to improving the health of the communities it serves.